Journal of Antimicrobial Chemotherapy

Journal of Antimicrobial Chemotherapy: optional open access and not-for-profit
pp. 799-802(4)
Authors: Reeves, David S.; Drummond, Colin W. E.; Hill, Mandy

Systematic reviews and meta-analyses in the Journal of Antimicrobial Chemotherapy
pp. 803-804(2)
Authors: Leibovici, Leonard; Reeves, David

Virucidal hand treatments for prevention of rhinovirus infection
pp. 805-807(3)
Authors: Turner, Ronald B.; Hendley, J. Owen

Once-daily antiretroviral therapy: Spanish Consensus Statement
pp. 808-818(11)
Authors: Pulido, F.; Ribera, E.; Muñoz, A.; Podzamczer, D.; del Pozo, M. A.; Rivero, A.; Rodríguez, F.; Sanjoaquín, I.; Teira, R.; Viciana, P.; Villalonga, C.; Antela, A.; Carmena, J.; Ena, J.; Gonzalez, E.; Kindelán, J. M.; Mallolas, J.; Márquez, M.; Martínez, E.

Characterization of the highly variable region surrounding the bla_CTX-M-9 gene in non-related Escherichia coli from Barcelona
pp. 819-826(8)
Authors: García, Aurora; Navarro, Ferran; Miró, Elisenda; Mirelis, Beatriz; Campoy, Susana; Coll, Pere

Molecular epidemiology of high-level aminoglycoside-resistant enterococci isolated from patients in a university hospital in southern Italy
pp. 827-835(9)
Authors: Zarrilli, Raffaele; Tripodi, Marie-Francoise; Di Popolo, Anna; Fortunato, Rosaria; Bagattini, Maria; Crispino, Margherita; Florio, Anna; Triassi, Maria; Utili, Riccardo

Differences in the DNA sequence of the translational attenuator of several constitutively expressed erm(A) genes from clinical isolates of Streptococcus agalactiae
pp. 836-840(5)
Authors: Culebras, Esther; Rodríguez-Avial, Iciar; Betriu, Carmen; Picazo, Juan J.

mef(A), mef(E) and a new mef allele in macrolide-resistant Streptococcus spp. isolates from Norway
pp. 841-846(6)
Authors: Sangvik, Maria; Littauer, Pia; Simonsen, Gunnar Skov; Sundsfjord, Arnfinn; Dahl, Kristin Hegstad

Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation
pp. 847-855(9)
Authors: Stevens, Miguel; Balzarini, Jan; Tabarrini, Oriana; Andrei, Graciela; Snoeck, Robert; Cecchetti, Violetta; Fravolini, Arnaldo; De Clercq, Erik; Pannecouque, Christophe

Characterization of the MacA–MacB efflux system in Neisseria gonorrhoeae
pp. 856-860(5)
Authors: Rouquette-Loughlin, Corinne E.; Balthazar, Jacqueline T.; Shafer, William M.

Serotonin and melatonin, neurohormones for homeostasis, as novel inhibitors of infections by the intracellular parasite chlamydia
pp. 861-868(8)
Authors: Rahman, Mohd. Akhlakur; Azuma, Yoshinao; Fukunaga, Hajime; Murakami, Tomoyuki; Sugi, Kazurou; Fukushi, Hideto; Miura, Koshiro; Suzuki, Harumi; Shirai, Mutsunori

In vivo activity of mutacin B-Ny266
pp. 869-871(3)
Authors: Mota-Meira, Marilaine; Morency, Helene; Lavoie, Marc C.

Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients
pp. 872-878(7)
Authors: Edmiston, Charles E.; Krepel, Candace J.; Kehl, Karen S.; Seabrook, Gary R.; Somberg, Lewis B.; Almassi, G. Hossein; Smith, Timothy L.; Loehrl, Todd A.; Brown, Kellie R.; Lewis, Brian D.; Towne, Jonathan B.

Use of Pseudomonas biofilm susceptibilities to assign simulated antibiotic regimens for cystic fibrosis airway infection
pp. 879-886(8)
Authors: Moskowitz, Samuel M.; Foster, Jessica M.; Emerson, Julia C.; Gibson, Ronald L.; Burns, Jane L.

Micafungin in combination with voriconazole in Aspergillus species: a pharmacodynamic approach for detection of combined antifungal activity in vitro
pp. 887-892(6)
Authors: Lewis, Russell E.; Kontoyiannis, Dimitrios P.

Comparison of β-lactam regimens for the treatment of Gram-negative pulmonary infections in the intensive care unit based on pharmacokinetics/pharmacodynamics
pp. 893-898(6)
Authors: Burgess, David S.; Frei, Christopher R.

Compartmental pharmacokinetics and tissue distribution of the antifungal triazole ravuconazole following intravenous administration of its di-lysine phosphoester prodrug (BMS-379224) in rabbits
pp. 899-907(9)
Authors: Groll, Andreas H.; Mickiene, Diana; Petraitis, Vidmantas; Petraitiene, Ruta; Kelaher, Amy; Sarafandi, Alia; Wuerthwein, Gudrun; Bacher, John; Walsh, Thomas J.

Interindividual variability of once-daily ritonavir boosted saquinavir pharmacokinetics in Thai and UK patients
pp. 908-913(6)
Authors: Autar, Reshma Saskia; Boffito, Marta; Hassink, Elly; Wit, Ferdinand W. N. M.; Ananworanich, Jintanat; Siangphoe, Umaporn; Pozniak, Anton; Cooper, David A.; Phanuphak, Praphan; Lange, Joep M. A.; Ruxrungtham, Kiat; Burger, David M.

Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey
pp. 914-918(5)
Authors: Arslan, Hande; Azap, Özlem Kurt; Ergönül, Önder; Timurkaynak, Funda

Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
pp. 919-922(4)
Authors: Yeh, Kuo-Ming; Chiueh, Tzong-Shi; Siu, L. K.; Lin, Jung-Chung; Chan, Paul K. S.; Peng, Ming-Yieh; Wan, Hsiang-Lin; Chen, Jenn-Han; Hu, Bor-Shen; Perng, Cherng-Lih; Lu, Jang-Jih; Chang, Feng-Yee

Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies
pp. 923-929(7)
Authors: Shorr, Andrew F.; Kunkel, Mark J.; Kollef, Marin

Determinants of antibiotic overprescribing in respiratory tract infections in general practice
pp. 930-936(7)
Authors: Akkerman, Annemiek E.; Kuyvenhoven, Marijke M.; van der Wouden, Johannes C.; Verheij, Theo J. M.

Effect of educational intervention on antibiotic prescription practices for upper respiratory infections in children: a multicentre study
pp. 937-940(4)
Authors: Razon, Yaron; Ashkenazi, Shai; Cohen, Avner; Hering, Eli; Amzel, Shlomo; Babilsky, Hanan; Bahir, Arie; Gazala, Eli; Levy, Itzhak

Treating patients not diagnoses: challenging assumptions underlying the investigation and management of LRTI in general practice
pp. 941-943(3)
Authors: Hopstaken, Rogier M.; Coenen, Samuel; Butler, Christopher C.

Reduced expression of the atl autolysin gene and susceptibility to autolysis in clinical heterogeneous glycopeptide-intermediate Staphylococcus aureus (hGISA) and GISA strains
pp. 944-947(4)
Authors: Wootton, Mandy; Bennett, Peter M.; MacGowan, Alasdair P.; Walsh, Timothy R.

Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli
pp. 948-950(3)
Authors: Cagliero, Cédric; Mouline, Christian; Payot, Sophie; Cloeckaert, Axel

Stability of heparin and physical compatibility of heparin/antibiotic solutions in concentrations appropriate for antibiotic lock therapy
pp. 951-953(3)
Authors: Robinson, Joan L.; Tawfik, Gerda; Saxinger, Lynora; Stang, Linda; Etches, Wai; Lee, Bonita

Long-term, controlled release of the HIV microbicide TMC120 from silicone elastomer vaginal rings
pp. 954-956(3)
Authors: Malcolm, R. Karl; Woolfson, A. David; Toner, Clare F.; Morrow, Ryan J.; McCullagh, Stephen D.

Cationic peptide of the male reproductive tract, HE2α, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis
pp. 957-961(5)
Authors: Liao, M.; Ruddock, P. S.; Rizvi, A. S.; Hall, S. H.; French, F. S.; Dillon, J. R.

Resistance among Escherichia coli to sulphonamides and other antimicrobials now little used in man
pp. 962-964(3)
Authors: Bean, David C.; Livermore, David M.; Papa, Iro; Hall, Lucinda M. C.

Distribution of fluoroquinolone MICs in Helicobacter pylori strains from Korean patients
pp. 965-967(3)
Authors: Kim, Jung Mogg; Kim, Joo Sung; Kim, Nayoung; Jung, Hyun Chae; Song, In Sung

Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines
pp. 968-974(7)
Authors: Protopopova, Marina; Hanrahan, Colleen; Nikonenko, Boris; Samala, Rowena; Chen, Ping; Gearhart, Jackie; Einck, Leo; Nacy, Carol A.

Evidence of vancomycin resistance gene transfer between enterococci of human origin in the gut of mice harbouring human microbiota
pp. 975-978(4)
Authors: Mater, Denis D. G.; Langella, Philippe; Corthier, Gérard; Flores, María José

Evaluation of ceftriaxone, vancomycin and rifampicin alone and combined in an experimental model of meningitis caused by highly cephalosporin-resistant Streptococcus pneumoniae ATCC 51916
pp. 979-982(4)
Authors: Ribes, Sandra; Taberner, Ferran; Domenech, Alejandro; Cabellos, Carmen; Tubau, Fe; Liñares, Josefina; Viladrich, Pedro Fernández; Gudiol, Francesc

Give them some clues: modelling antibiotic resistance
pp. 983-984(2)
Author: Magee, J. T.

Mathematical modelling of resistance emergence
pp. 983-983(1)
Authors: Tam, Vincent H.; Nikolaou, Michael

Disagreements between disc diffusion, and MIC-based susceptibility categorizations of ertapenem versus ESBL producers
pp. 984-985(2)
Authors: Samuel, Julie R.; Natarajan, Manjula; Rizkalla, Essam; Livermore, David M.; Warner, Marina; Jenkinson, Peter

Macrolide, lincosamide and streptogramin B resistance in a dominant clone of Australian community methicillin-resistant Staphylococcus aureus
pp. 985-986(2)
Authors: O'Brien, Frances G.; Zaini, Zainun; Coombs, Geoffrey W.; Pearson, Julie C.; Christiansen, Keryn; Grubb, Warren B.

Spread of multiresistance and extended-spectrum β-lactamases amongst urinary Escherichia coli in Oxford, UK
pp. 986-988(3)
Authors: Wyllie, David H.; Baxter, Emma; Morgan, Marcus; Bowler, Ian C. J. W.

Surveillance for resistance to metronidazole and vancomycin in genotypically distinct and UK epidemic Clostridium difficile isolates in a large teaching hospital
pp. 988-989(2)
Authors: Freeman, Jane; Stott, Joanna; Baines, Simon D.; Fawley, Warren N.; Wilcox, Mark H.

The OPTAMA programme: utilizing MYSTIC (2002) to predict critical pharmacodynamic target attainment against nosocomial pathogens in Europe
pp. 990-990(1)
Authors: Masterton, Robert G.; Kuti, Joseph L.; Turner, Philip J.; Nicolau, David P.